Cell death in mammalian development

Current Pharmaceutical Design

Volumn 14, Issue 2, 2008, Pages 184-196

  Penaloza, C ^a   Orlanski, S ^a   Ye, Y ^a   Entezari Zaher, T ^b   Javdan, M ^c   Zakeri, Zahra ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Autophagy; Embryonic development; Necrosis; Programmed cell death

Indexed keywords

BECLIN 1; BIM PROTEIN; CALPAIN; CASPASE 10; CASPASE 11; CASPASE 14; CASPASE 2; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; GENE PRODUCT; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BID; PROTEIN DERIVATIVE; PROTEIN MCL 1; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TERATOGENIC AGENT;

AUTOPHAGY; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL FATE; CELL MOTION; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; GENE CONTROL; GENE IDENTIFICATION; MAMMAL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CONGENITAL DISORDER; DRUG EFFECT; GENETICS; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DEATH; CONGENITAL ABNORMALITIES; EMBRYONIC DEVELOPMENT; MAMMALS; TERATOGENS;

EID: 38949150822     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783378789     Document Type: Review

References (204)

1. Lockshin RA, Williams CM. Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol 1964; 10: 643-9.
2. Penaloza C, Lin L, Lockshin RA, Zakeri Z. Cell death in development: shaping the embryo. Histochem Cell Biol 2006; 126(2): 149-58.
3. Kerr JF WA, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4): 239-57.
4. Dupont-Versteegden E. Apoptosis in skeletal muscle and its relevance to atrophy. World J Gastroenterol 2006; 12(46): 7463-6.
5. Malhi H, Gores GJ. TRAIL resistance results in cancer progression: A TRAIL to perdition? Oncogene 2006; 25(56): 7333-5.
6. Fumarola C, Guidotti GG. Stress-Induced apoptosis: Toward a symmetry with receptor-mediated cell death. Apoptosis 2004; 9(1): 77-82.
7. Ashkenazi A, Dixit VM. Death Receptors: Signaling, and Modulation. Science 1998; 281(5381): 1305-8.
8. Ashe PC, Berry, Mark D. Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27(2): 199-214.
9. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14(22): 5579-88.
10. Siegel PM. DD, Muller, WJ. Oncogene mediated signal transduction in transgenic mouse models of human breast cancer. Adv Exp Med Biol 2000; 480: 185-94.
11. Aravind L, Dixit VM, Koonin EV. The domains of death: Evolution of the apoptosis machinery. Trends Biochem Sci 1999; 24(2): 47-53.
12. Hofmann K. The modular nature of apoptotic signaling proteins. Cell Mol Life Sci 1999; 55(8-9): 1113-28.
13. Denecker G VD, Declercq W, Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 2001; 58(3): 356-70.
14. Salvesen GS, Dixit VM. Caspase activation: The induced-proximity model. Proc Natl Acal Sci USA. 1999; 96(20): 10964-7.
15. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002; 296(5573): 1635-6.
16. Kumar A, Sinha RA, Tiwari M, Singh R, Koji T, Manhas N, et al. Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways. J Hepatol 2007; 46(5): 888-98.
17. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13(15): 1899-911.
18. Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnoczky G. Rapid kinetics of tbid-induced cytochrome c and smac/diablo release and mitochondrial depolarization. J Biol Chem 2002; 277(7): 5651-9.
19. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, et al. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 2002; 99(9): 3419-26.
20. Bratton SB, Cohen GM. Apoptotic death sensor: An organelle's alter ego? Trends Pharmacol Sci 2001; 22(6): 306-15.
21. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3(11): E255-E63.
22. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, htra2, is released from the mitochondria and interacts with xiap, inducing cell death. Mol Cell 2001; 8(3): 613-21.
23. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitocbondria. Nature 21001; 412(6842): 95-9.
24. Sun X-M, Bratton SB, Butterworth M, MacFarlane M, Cohen GM. Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein. J Biol Chem 2002; 277(13): 11345-51.
25. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000; 275(40): 31199-203.
26. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002; 9(2): 423-32.
27. Cain K, Bratton SB, Langlais C, Walker G, Brown DG, Sun X-M, et al. Apaf-1 oligomerizes into biologically active ∼700-kda and inactive ∼1.4-mda apoptosome complexes. J Biol Chem 2000; 275(9): 667-70.
28. Gogvadze V, Orrenius S. Mitochondrial regulatibn of apoptotic cell death. Chem Biol Interact 2006; 163(1-2): 4-14.
29. Yoshida H, Kong Y-Y, Yoshida R, Elia AJ, Hakem A, Hakem R, et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94(6): 739-60.
30. Srinivasula SM, Datta P, Fan X-J, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of smac/ diablo and its role in the death receptor pathway. J Biol Chem 2000; 275(46): 36152-7.
31. Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, et al. Induction of caspase 8 by interferon {gamma} renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res 2003; 63(5): 1122-9.
32. Potts PR, Singh S, Knezek M, Thompson CB, Deshmukh M. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 2003; 163(4): 789-99.
33. Honda Y, Tanikawa H, Fukuda J, Kawamura K, Sato N, Sato T, et al. Expression of Smac/DIABLO in mouse preimplantation embryos and its correlation to apoptosis and fragmentation. Mol Hum Reprod 2005; 11(3): 183-8.
34. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407(6805): 770-6.
35. Cory S, Adams JM. The BCL2 family: Regulators of the cellular life-or-death switch. Nature Rev Cancer 2002; 4(9): 647-56.
36. Breckenridge DG GM, Mathai JP, Nguyen M, Shore GC. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003; 22(53): 8608-18.
37. Germain M SG. Cellular distribution of Bcl-2 family proteins. Sci STKE 2003; 173: Pe10.
38. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001; 26(1): 61-6.
39. Tsujimoto Y, Shimizu S. Bcl-2 family: Life-or-deadl switch. PEBS Lett 2000; 466(1): 6-10.
40. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003; 195(2): 158-67.
41. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003; 4(5): 410-5.
42. LeBlanc AC. Natural cellular inhibitors of caspases. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27(2): 215-29.
43. Kidd VJ, Lahti JM, Teitz T. Proteolytic regulation of apoptosis. Semin Cell Devel Biol 2000; 11(3): 191-201.
44. Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273(16): 9357-60.
45. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PWK. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 1998; 394(6694): 700-4.
46. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999; 6(6): 508-15.
47. Leist M, Jäättelä M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2(8): 589-98.
48. Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Curr Opin Cell Biol 2002; 14(6): 727-33.
49. Jaattela M, Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 2003; 4(5): 416-23.
50. Johnson DE, Gastman BR, Wieckowski E, Wang G-Q, Amoscato A, Delach SM, et al. Inhibitor of apoptosis protein hILP undergoes caspase-madiated cleavage during t lymphocyte apoptosis. Cancer Res 2000; 60(7): 1818-23.
51. Turk V, Turk B, Turk D. Lysosomal cysteine proteases: Facts and opportunities. EMBO J 2001; 20(17): 4629-33.
52. Mathiasen IS, Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2062; 8(5): 212-20.
53. Fehrenbacher N, Gyid-Hansen M, Poulsen B, Felbor U, Kallunki T, Boes M, et al. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res 2004; 64(15): 5301-40
54. Keppler D SB. Cathepsin B: Multiple enzyme forms from a single gene and their relation to cancer. Enzyme Protein 1996; 49(1-3): 94-105.
55. Foghsgaard L, Wilssing D, Mauch D, Lademann U, Bastholm L, Boes M, et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001; 153(5): 999-1010.
56. Roberg K. Relocalization of cathepsin D and cytochrome c early in apoptosis revealed by immunoelectron microscopy. Lab Invest 2001; 81(2): 149-58.
57. Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ. Cathepsin B knockout mice are resistant to tumor necrosis factor-{alpha}-mediated hepatocyte apoptosis and liver injury: Implications for therapeutic applications. Am J Pathol 2001; 159(6): 2045-54.
58. Novikoff AB, Beaufay H, de Duve C. Electron microscopy of lysosome-rich fractions from rat liver. J Cell Biol 1956; 2(4): 179-84.
59. Zuzarte-Luis V, Montero JA, Torre-Perez N, Garcia-Porrero JA, Hurle JM. Cathepsin D gene expression outlines the areas of physiological cell death during embryonic development. Dev Dyn 2007; 236(3): 880-5.
60. Guroff G. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem 1964; 239(1): 149-55.
61. Imajoh S, Kawasaki H, Suzuki K. Limited autolysis of calcium-activated neutral protease (CANP): Reduction of the Ca2+-requirement is due to the NK2-tenninal processing of the large subunit. J Biochem (Tokyo) 1986; 100(3): 633-42.
62. Molinari M, Anagli J, Carafoli E. Ca(2+)-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. J Biol Chem 1994; 269(45): 27992-5.
63. Ray SK, Matzelle DD, Sribnick EA, Guyton MK, Wingrave JM, Banik NL. Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat 2003; 26(2): 119-24.
64. Liou J-Y, Aleksic N, Chen S-F, Han T-J, Shyue S-K, Wu KK. Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: Implication in apoptosis resistance. Exp Cell Res 2005; 306(1): 75-84.
65. Paquet-Durand F, Azadi S, Hauck SM, Ueffing M, Veen T, Ekstrom P. Calpain is activated in degenerating photoreceptors in the rdl mouse. J Neurochem 2006; 96(3): 802-14.
66. Clark SL Jr. Cellular differentiation in the kidneys of newborn mice studied with the electron microscope. J Cell Biol 1957; 3(3): 349-62
67. Schweichel JU MH. The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7(3):253-66.
68. Thummel CS. Steroid-triggered death by autophagy. Bioessays 2001; 23(8): 677-82.
69. Ogier-Denis E, Codogno P. Autophagy: A barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603(2): 113-28.
70. van Sluijters DA, Dubbelhuis PF, Blommaart EF, Meijer. AJ. Amino-acid-dependent signal transduction. Biochem J 2000; 351(3): 545-50.
71. Seglen PO, Gordon PB.-3-Methyladenine: Specific inhibitor of autophagic/ lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 1982; 79(6): 1889-92.
72. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, et al. Autophagy Gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007; 128(5): 931-46.
73. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142(1): 67-77
74. Zong W-X, Thompson CB, Necrotic death as a cell fate. Genes Dev 2006; 20(1): 1-15.
75. Chautan M, Chazal & Cecconi F, Gruss P, Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol 1999; 9(17): 967-70.
76. Lockshin RA, Beaulton J. Cell death: Questions for histochemists concerning the causes of the various cytological change. Histochem J 1981; 13(4): 659-66.
77. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Ann Rev Pharmacol Toxicol 2002; 42(1): 259-81.
78. Niquet J, Liu H, Wasterlain CG. Programmed neuronal necrosis and status epilepticus. Epilepsia 2005; 46(5):43-8.
79. Kaistura J, Bolli R, Sonnenblick EH, Anversa P, Leri A. Cause of death: suicide. J Mol Cell Cardiol 2006; 40(4): 425-37.
80. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of easpases and bypasses Bcl-2. Proc Natl Acal Sci USA 2000; 97(14): 7871-6.
81. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acal Sci USA 1999; 96(24): 13978-82.
82. Holler N, Zaru R, Micheau, Q, Thorne, M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent clll death pathway using the kinase RIP as effector molecule. Nat Immumol 2000; 1(6): 489-95.
83. Vercammen D, Beyaert R, Denecker G, Goossen V, Van Loo G. Declerq W, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998:,187(9): 1477-85.
84. Ledda-Columbano GM, Coni P, Curto M, Giacommi L, Faa G, Oliverio S, et al. Induction of two different modes of cell death, apoptosis and neorosis, in rat liver after a single dose of thio-acetamide. Am J Pathol 1991; 139(5): 1099-109.
85. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, ahd tumorigenesis. Cancer Cell 2006; 10(1): 51-64.
86. Hardy K, Handyside AH, Winston RM. The human blastooyst: Cell number, death and allocation during late preimplantanon development in vitro. Development 1989; 107(3): 5 97-604.
87. Spanos S, Rice S, Karagiannis P, Taylor D, Becier DL, Winston RM, et al. Caspase activity and expression of cell death genes during development of human preimplantation embryos. Reproduction 2002; 124(3): 353-63.
88. Zakeri Z LR, Criado-Rodriguez LM, Martinez-A C. A generalized caspase inhibitor disrupts early mammalian development. Int J Dev Biol 2005; 49(1): 43-7.
89. Kamjoo M, Brison DR, Kimber SJ. Apoptosis in the preimplantation mouse embryo: Effect of strain difference and in vitro culture. Mol Reprod Dev 2002; 61(1): 67-77.
90. Long CR, Dobrinsky JR, Garret WM, Johnson LA. Dual labeling of the cytoskeleton and DNA strand breaks in porcine embryos produced in vivo and in vitro. Mol Reprod Dev 1998; 51(1): 59-65.
91. Hardy K. Apoptosis in the human embryo. Rev Reprod 1999; 4(3): 125-34
92. Yang HW, Hwang KJ, Kwon HC, Kim HS, Choi KW, Oh KS. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod 1998; 13(4): 998-1002.
93. Fabian, K, Maddox H. Apoptotic processes during mammalian preimplantation development. Theriogenology 2005; 64(2): 221-31.
94. Byrne AT, Southgate J, Brison DR, Leese HJ. Analysis of apoptosis in the preimplantation bovine embryo using TUNEL. J Reprod Fertil 1999; 177(1): 97-105.
95. Sanders EJ, Torkkeli PH, French AS. Patterns of cell death during gastrulation in chick and mouse embryos. Anat Embryol 1997; 195(2): 147-54.
96. Manova Katia, Tomihara-Newberger C, Wang S, Godelman A, Kalantry, Witty-Blease K, et al. Apoptosis in mouse embryos: Elevated levels in pregastrulae and in the distal anterior region of gastrulae of normal and mutant mice. Dev Dyn 1998; 213(3): 293-308.
97. Vilovic K SD, Ilijic E, Mimica MD, England MA, Saraga-Babic M. Morphological characteristics of dying cells in axial structures of developing human embryos. Cells Tissues Organs 2001; 169(4): 347-54
98. Gao J, Gulber-Schwalb TA, Addeo JV, Stern ME. Apoptosis in the rabbit cornea after photorefractive keratectomy: Cornea 1997; 16(2): 200-8
99. Mohamed YH, Amemiya T. Apoptosis.and lens vesicle development. Eur J Ophthalmol 2003; 13(1): 1-10.
100. Abdelwahid E, Pelliniemi LJ, Jokinen E. Cell death and differentiation in the development of the endocardial cushion of the embryonic heart. Microsc Res Tech 2002; 58(5): 395-403.
101. Lee DM, Osathanondh R, Yeh J. Localization of Bcl-2 in the human fetal mullerian tract. Fertil Steril 1998; 70(1): 135-40.
102. Reynaud K, Driancourt MA. Oocyte attrition. Mol Cell Endocrinol 2000; 163(1-2): 101-8.
103. Carev D, Krni D, Saraga, M, Sapunar D, Saraga-Babi M. Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development. Pediatric Nephrol 2006; 21(5): 627-36.
104. de Torres C, Munell F, Roig M, Reventós J, Macaya A. Naturally occurring cell death during postnatal development of rat skeletal muscle. Muscle Nerve 2002; 26(6): 777-83.
105. Ballard KJ, Holt SJ. Cytological and cytocchemical studies on cell death and digestion in the foetal rat foot: The role of macrophages and hydrolytic enzymes. J Cell Sci 1968; 3(2): 245-62.
106. Zakeri ZF, Ahuja HS. Apoptotic cell death in the limb, and its relationship to pattern formation. Biochem Cell Biol 1994; 72(11-12): 603-13.
107. Hurle JM, Colombatti A. Extracellular matrix modifications in the interdigital spaces of the chick embryo leg bud during the formation of ectopic digits. Anat Embryol 1996; 193(4): 355-64.
108. Zakeri Z, Quaglino D, Ahuja HS. Apoptotic cell death in the mouse limb and its suppression in the hammertoe mutant. Dev Biol 1994; 165(1): 294-7.
109. Ganan Y, Macias D, Basco RD, Merino R, Hurle JM. Morphological diversity of the avian foot is related with the pattern of msx gene expression in the developing autopod. Dev Biol 1998; 196(1): 33-41.
110. Wang C-KL, Omi M, Ferrari D, Cheng H-C, Lizarraga G, Chin H-J, et al. Function of BMPs in the apical ectoderm of the developing mouse limb. Dev Biol 2004; 269(1): 109-22.
111. Glucksmann A. Cell Deaths in normal vertebrate ontogeny. Biol Rev 1951; 26: 59-86.
112. Gordon N. Apoptosis (programmed cell death) and other reasons for elimination of neurons and axons. Brain Dev 1995; 17(1): 73-7.
113. Barres BA, Raff MC. Axonal control of oligodendrocyte development. J Cell Biol 1999; 147(6): 1123-8.
114. Clarke PGH, Posada A, Primi MP, Castagne V. Neuronal death in the central nervous system during development. Biomed Pharmacother 1998; 52(9): 356-62.
115. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88(3): 347-54.
116. Reis RA, Cabral da Silva MC, Loureiro, dos Santos NE, Bampton E, Taylor JS, de Mello FG, et al. Sympathetic neuronal survival induced by retinal trophic fa6tors. J Neurobiol 2002; 50(1): 13-23.
117. Vyas S, Bechade C, Riveau B, Downward J, Triller A. Involvement of survival motor neuron (SMN) protein in cell death. Hum Mol Genet 2002; 11(22): 2751-64.
118. Galli-Resta L, Ensini M. An intrinsic time limit between genesis and death of individual neurons in the developing retinal ganglion cell layer. J Neurosci 1996; 16(7): 2318-24.
119. Blaschke AJ, Staley K, Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex Development 1996; 122(4): 1165-74.
120. Thomaidou D, Mione MC, Cavanagh JFR, Parnavelas JG. Apoptosis and Its Relation to the Cell Cycle in the Developing Cerebral Cortex. J Neurosci 1997; 17(3): 1075-85.
121. Lossi L, Zagazg D, Greco MA, Merighi A, Apoptosis of undifferentiated progenitors and granule cell precursors in the postnatal human cerebellar cortex correlating with expression of BCL-2, ICE, and CPP32 proteins. J Comp Neurol 1998; 399(3): 359-72.
122. Lossi L, Coli A, Giannessi E, Stornelli MR, Marroni P. Cell proliferation and apoptosis during histogenesis of the guinea pig and rabbit cerebellar cortex. Ital J Anat Embryol 2002; 107(2): 117-22.
123. Compton M. A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome. Cancer Metastasis Rev 1992; 11(2): 105-19
124. Exley GE, Tang C, McElhinny AS, Warner CM. Expression of caspase and BCL-2 apoptotic family members in mouse preimplantation embryos. Biol Reprod 1999; 61(1): 231-9.
125. Carol M. Warner GEE, McElhinny SA, Tang C. Genetic regulation of preimplantation mouse embryo survival. The J Expl Zoology 1998; 282(1-2): 272-9.
126. Jurisicova A, Antenos M, Varmuza S, Tilly JL, Casper RF. Expression of apoptosis-related genes during human preimplantation embryo development: potential roles for the Harakiri gene product and Caspase-3 in blastomere fragmentation. Mol Hum Reprod 2003; 9(3): 133-41.
127. Metcalfe AD, Hunter HR, Bloor DJ, Lieberman BA, Picton HM, Leese HJ, et al. Expression of 11 members of the BCL-2. family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation. Mol Reprod Dev 2004; 69(1): 35-50.
128. Jurisicova A, Latham KE, Casper RF, Casper RF, Varmuza SL. Expression and regulation of genes associated with cell death during murine preimplantation embryo developmedt. Mol Reprod Dev 1998; 51(3): 243-53.
129. Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, et al. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant, Proc Natl Acal Sci USA 1998; 95(21): 12424-31.
130. Carter AD, Sible JC. Loss of XChk1 function triggers apoptosis after the midblastula transition in Xenopus laevis embryos. Mech Dev 2003; 120(3): 315-23.
131. Finkielstein CV, Lewellyn AL, Maller JL. The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage. Proc Natl Acal Sci USA 2001; 98(3): 1006-11.
132. Oltvai ZN, Millman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74(4): 609-19.
133. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Irie S, Fong L, et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994; 54(21): 5501-7.
134. Deckwerth TL, Elliott JL, Knudson CM, Johnson EM, Snider WD, Korsmeyer SJ. BAX Is required for neuronal death after trophic factor deprivation and during development. Neuron 1996; 17(3): 401-11.
135. Hardy K, Spanos S, Becker D, Iannelli P, Winston RM, Stark J. From cell death to embryo arrest: Mathematical models of human preimplantation embryo development. Proc Natl Acal Sci USA 2001; 98(4): 1655-60.
136. Motoyama N, Wag F, Roth KA, Sawa H, Nakayama K, Nakayama K, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267(5203): 1506-10.
137. Roth KA, D'Sac C. Apoptosis and brain development. Ment Retard Dev Disabil Res Rev 2001; 7(4): 261-6.
138. Ushizawa K, Takahashi T, Kaneyama K, Hosoe M, Hashizume K. Cloning of the bovine antiapoptotic regulator, BCL2-Related protein A1, and its expression in trophoblastic binucleate cells of bovine placenta. Biol Reprod 2006; 74(2): 344-51.
139. Yamada O, Todoroki J, Kizaki K, Takahashi T, Imai K, Patel OV, et al. Expression of prolactin-related protein I at the fetomaternal interface during the implantation period in cows. Reproduction 2002; 124(3): 427-37.
140. Wooding FB, Morgan G, Monaghan S, Hamon M, Heap RB. Functional specialization in the ruminant placenta: Evidence for two populations of fetal binucleate cells of different selective synthetic capacity. Placenta 1996; 17(1): 75-86.
141. Wei P, Jin X, Zhang XS, Hu ZY, Han CS, Liu YX. Expression of Bcl-2 and p53 at the fetal-maternal interface of rhesus monkey. Reprod Biol Endocrinol 2005; 3: 4.
142. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4(12): 1421-4.
143. Pampfer S, Cordi S, Vanderheyden I, Van Der Smissen P, Courtoy PJ, Van Cauwenberge A, et al. Expression and role of Bcl-2 in rat blastocysts exposed to high D-glucose. Diabetes 2001; 50(1): 143-9.
144. Correia-da-Silva G, Bell SC, Pringle JH, Teixeira NA. Patterns of expression of Bax, Bcl-2 and Bcl-xL in the implantation site in rat during pregnancy. Placenta 2005; 26(10): 796-806.
145. Kawamura K, Sato N, Fukuda J, Kodama H, Kumagai J, Tanikawa H, et al. Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev Biol 2003; 256(2): 331-41.
146. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189(2): 381-94.
147. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CYJ, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410(6828): 549-54.
148. Varfolomeev EE, Schuchmmn M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9(2): 267-76.
149. Kang T-B, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, et al. Caspase-8 serves both apoptotic and non-apoptotic roles. J Immunol 2004; 173(5): 2976-84.
150. Kuida K, Zheng TS, Na S, Kuan C-Y, Yang D, Karasuyama H, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384(6607): 368-72.
151. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94(3): 325-37.
152. Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nat Genet 2001; 28(2): 113-8.
153. Van Blerkom J, Davis P, Alexander S. A microscopic and biochemical study of fragmentation phenotypes in stage-appropriate human embryos. Hum Reprod 2001; 16(4): 719-29.
154. Xue L, Fletcher GC, Tolkovsky AM. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr Biol 2001; 11(5): 361-5.
155. Antczak M, Van Blerkom J. Temporal and spatial aspects of fragmentation in early human embryos: Possible effects on developmental competence and association with the differential elimination of regulatory proteins from polarized domains. Hum Reprod 1999; 14(2): 429-47.
156. Donovan M, Cotter TG. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 2004; 1644(2-3): 133-47.
157. Kuan C-Y, Roth KA, Flavell RA, Rakic P. Mechanisms of programmed cell death in the developing brain. Trends Neurosci 2000; 23(7): 291-7.
158. Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A, et al. Defects in regulation of apoptosis in caspase-2 -deficient mice. Genes Dev 1998; 12(9): 1304-14.
159. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beolin I, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100(25): 15077-82.
160. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57(7): 1083-93.
161. Baker SJ MS, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249(4971): 912-5.
162. Yonish-Rouach E, Resnftzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352(6333): 345-7.
163. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995; 15(6): 3032-40.
164. Gadducci A, Cosio S, Muraca S, Genazzani AR. Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: Biological data and clinical implications. Eur J Gynaecol Oncol 2002; 23(5): 390-6.
165. Miyashita T, Krojewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9(6); 1799-805.
166. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356(6366): 215-21.
167. Ucker D. Death by suicide: One way to go in mammalian cellular development? New Biol 1991; 3(2): 102-9.
168. Rubin E, Rottenberg H. Ethanol-induced injury and adaptation in biological membranes. Fed Proc 1982; 41(8): 2465-71.
169. Kung AL, Zetterberg A, Sherwood SW, Schimke RT. Cytotoxic effects of cell cycle phase specific agents: Results of cell cycle perturbation. Cancer Res 1990; 50(22): 7307-17.
170. Sen S, D'Incalci M. Apoptosis biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992; 307(1): 122-7.
171. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acal Sci USA 1994; 91(9): 3754-8.
172. Lew J, Wang JH. Neuronal cdc2-like kinase. Trends Biochem Sci 1995;20(1):33-7.
173. Ahuja HS, James W, Zakeri Z. Rescue of the limb deformity in Hammertoe mutant mice by retinoic acid-induced cell death. Dev Dyn 1997; 208(4): 466-81.
174. Fu WY, Wang JH, Ip NY. Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation. J Neurochem 2002, 81(3): 646-54.
175. Zhu Y, Lin L, Kim S, Quaglino D, Lockshin RA, Zakeri Z. Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos. Cell Death Differ 2002; 9(4): 421-30.
176. Zhang Q, Ahuja HS, Zakeri ZE, Wolgemuth DJ. Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev Biol 1997; 183(2): 222-33.
177. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999; 402(6762): 615-22.
178. Ahuja HS, James W, Zakeri Z. Rescue of the limb deformity in Hammertoe mutant mice by retinoic acid-induced cell death. Dev Dyn 1997; 208(4): 466-91.
179. Shepard JL, Olsen B, Tedengren M, Bradley BP. Protein expression signatures identified in Mytilus edulis exposed to PCBs, copper and salinity stress. Mar Environ Res 2000; 50(1-5): 337-40.
180. Menkes BDM, Prelipceanu O, Capalnasan I. Appearance, concentrationand localization of normogenic and teratogenic substances in necrosis zones of the embryo. Morphol Embryol (Bucur) 1977; 23(1): 27-34.
181. Moore RW, Jefeoate CR, Peterson RE. 2,3,7,8-Tetrachlorodibenzop-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol Appl Pharmacol 1991; 109(1): 85-97.
182. Selvakumar E, Prahalathan C, Varalakshmi P, Kumarasamy P, Saravanan R. Modification of cyclophosphamide-induced clastogenesis and apoptosis in rats by [alpha]-lipoic acid. Mutat Res 2006; 606(1-2): 85-91.
183. Jezernik K, Romih R, Mannherz HG, Koprivec D. Immunohistochemical detection of apoptosis proliferation and inducible nitric oxide synthase in rat urothelium damaged by cyclophosphamide treatment. Cell Biol Int 2003; 27(10): 863-9.
184. Gimson JE, Becker BA. The teratogenicity of cyclophosphamide in mice. Cancer Res 1969; 28(3): 475-80.
185. Hales B. Modification of the mutagonicity and teratogenicity of cyclophosphamide in rats with inducers of the cyrochromes P-450. Teratology 1981; 1: 1-11.
186. Torchinsky A, Savion S, Gorivodsky M, Shepshelovich J, Zaslavsky Z, Fein A, Toder V. Cyclophosphamide-induced teratogenesis in JCR mice: The role of apoptosis. Teratog Carcinog Mutagen 1995; 15(4): 179-90.
187. Chunwei Huang BFH. Role of caspases in routine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide. Teratology 2002; 66(6): 288-99.
188. Little SA, Kim WK, Mirkes PE. Teratoged-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos. Cell Biol Toxicol 2003; 19(4): 215-26.
189. Little SA, Mirkes PE. Teratogen-induced activation of caspase-9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos. Toxicol Appl Pharmacol 2002; 181(2): 142-51.
190. Mirkes, PE, Little SA. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol Appl Pharmacol 2000; 162(3): 197-206.
191. Schwartz PS, Waxman DJ. Cycloposphamide induces caspase 9-dependent apoptosis in 91 tumor cells. Mol Pharmacol 2001; 60(6): 1268-79.
192. Ohtani T, Nakamura T, Toda K-i, Furukawa F. Cyclophosphamide enhances TNF-[alpha]-induced apoptotic cell death in murine vascular endothelial cell. FEB S Lett 2006; 580(6): 1597-600.
193. Sporn MBR, Anita B. Cervical dysplasia regression induced by alltrans-retinoic acid. J Natl Cancer Inst 1994; 86(7): 476-7.
194. Mangelsdorf D. Vitamin A receptors. Nutr Rev 1994; 52(2 Pt 2): S12-44.
195. Gumireddy K, Sutton LN, Phillips PC, Reddy CD. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: Activation of caspase-3/ Poly(ADP-ribose) polymerase 1 pathway, Clin Cancer Reg 2003; 9(11): 4052-9.
196. Rogers MB, Glozak MA, Heiler LC. Induction of altered gene expression in early embryos. Mutat Res 1997; 396(1-2): 79-95.
197. Zakcri ZF. In vitro mammalian limb differentiation as an experimental model. Prog Clin Biol Res 1993; 383A: 361-70.
198. Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a ysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60, cells. Cell Death Differ 2001; 8(5): 477-85.
199. Alisi A, Leoni S, Piacentani A, Contí Devirgiliis L. Retinoic acid modulates the cell-cycle in fetal rat bepatocytes and HepG2 cells by regulating cyclin-cdk activities. Liver Int 2003; 23(3): 179-86.
200. Hume DA PV, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Rec 1984; 210(3): 503-12
201. Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 2003; 199(2): 221-8.
202. Borsello T, Forloni G. JNK signalling: A possible target to prevent neurodegeneration. Curr Pharm Des 2007; 13(18): 1875-86.
203. Flick B, Klug S. Whole embryo culture: An important tool in developmental toxicology today. Curr Pharm Des 2006; 12(12): 1467-88
204. Georgiev P, Dahm F, Graf R, Clavien PA. Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver. Curr Pharm Des 2006; 12(23): 2911-21.